Abstract

Mitochondrial carriers catalyse the translocation of numerous metabolites across the inner mitochondrial membrane, playing a key role in different cell functions. For this reason, mitochondrial carrier gene expression needs tight regulation. The human SLC25A13 gene, encoding for the mitochondrial aspartate/glutamate carrier isoform 2 (AGC2), catalyses the electrogenic exchange of aspartate for glutamate plus a proton, thus taking part in many metabolic processes including the malate-aspartate shuttle. By the luciferase (LUC) activity of promoter deletion constructs we identified the putative promoter region, comprising the proximal promoter (−442 bp/−19 bp), as well as an enhancer region (−968 bp/−768 bp). Furthermore, with different approaches, such as in silico promoter analysis, gene silencing and chromatin immunoprecipitation, we identified two transcription factors responsible for SLC25A13 transcriptional regulation: FOXA2 and USF1. USF1 acts as a positive transcription factor which binds to the basal promoter thus ensuring SLC25A13 gene expression in a wide range of tissues. The role of FOXA2 is different, working as an activator in hepatic cells. As a tumour suppressor, FOXA2 could be responsible for SLC25A13 high expression levels in liver and its downregulation in hepatocellular carcinoma (HCC).

Highlights

  • The human aspartate/glutamate carrier isoform 2 (AGC2), encoded by the SLC25A13 gene, is a member of the mitochondrial carrier family [1,2]

  • We have investigated the transcriptional regulation of SLC25A13 and identified two transcriptional factors, USF1 and FOXA2, that act as positive regulators of the SLC25A13 gene expression

  • When FOXA2 or USF1 genes were silenced we obtained a great reduction in NAD+/NADH ratio; this reduction was even greater in the presence of FOXA2/USF1 double gene silencing (Figure 5B). These findings suggest a role for FOXA2 and USF1 as regulators of AGC2 activity implying their control of the NADH redox status

Read more

Summary

Introduction

The human aspartate/glutamate carrier isoform 2 (AGC2), encoded by the SLC25A13 gene, is a member of the mitochondrial carrier family [1,2] This family of transporters translocates a variety of metabolites across the mitochondrial membrane, linking biological and metabolic processes occurring in both mitochondria and cytosol [3,4]. Humans possess another isoform of the aspartate-glutamate carrier, AGC1, which is encoded by the SLC25A12 gene. A specific involvement of AGC1 in hepatocellular carcinoma (HCC) and N-acetylaspartate synthesis in mice lacking AGC1 has been reported [21,22]

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call